Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. It is a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life expectancy are unclear. It is given by injection under the skin.
Keywords
Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH; Liraglutide
Citations
Publication ()
Have you cited DAG-WT5770K in a publication? Let us know and earn a reward for your research.
My Review for Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH [KLH]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
